Navigation Links
Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
Date:9/5/2007

HAYWARD, Calif., Sept. 5 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) announced today that Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and CEO, will present at the Bear Stearns 20th Annual Healthcare Conference in New York at the Grand Hyatt on Monday, September 10, 2007 at 10:30 a.m. Eastern Time. A live webcast of the presentation can be accessed through http://cc.talkpoint.com/BEAR002/091007a_sc/?entity=kosan.

Interested parties may also access a live webcast of the presentation by visiting the "Events Calendar" page under the "Investors/Press" tab on Kosan's website at http://www.kosan.com. A recorded replay of the presentation will be available for two weeks.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib in patients with multiple myeloma in a registration program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with Herceptin, and as monotherapy in metastatic melanoma. Intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), ar
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Utah , April 21, 2015  Tute Genomics, a ... hiring of Josh Forsythe as VP of Marketing. ... has witnessed a significant expansion in its commercial operations over ... " Josh Forsythe is a tremendous ... , MD MBA, CEO of Tute Genomics. "Josh,s vast experience ...
(Date:4/21/2015)... SYDNEY , April 21, 2015  Novogen Limited ... Australian/US biotechnology company, advises that it has entered ... million fully-paid ordinary shares plus one attaching 6-month ... for every ordinary share issued, to institutional investors ... in a private placement for aggregate gross proceeds ...
(Date:4/21/2015)... SILVER SPRING, Md. and RESEARCH ... -- United Therapeutics Corporation (NASDAQ: UTHR ) announced ... financial results before market open on Tuesday, April 28, ... teleconference on Tuesday, April 28, 2015, at 9:00 a.m. ... with international callers dialing 1-970-315-0533.  A rebroadcast of the ...
(Date:4/21/2015)... 21, 2015 Leading-edge research ... applications will be presented at the 2nd ... regulators and clinicians from academia, industry and ... by Invibio Biomaterial Solutions. The world-leading solutions ... in manufacturing and R&D for medical-device manufacturers, ...
Breaking Biology Technology:Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 2Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 62nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3
... Jan. 31 Koronis Pharmaceuticals, Inc., a,biotechnology company ... the appointment of Daniel H. Petree and George ... Mr. Petree is a founder and member ... in life science companies. Prior to forming P2,Partners, ...
... EVENT ... DATE, Publication of the Annual Report for 2007 ... Wednesday, April 23, 2008, Publication ... 2008, Publication of the Interim Report for the Wednesday, August 27, 2008 ...
... UPTON, NY - In an achievement some see as ... Department of Energy,s Brookhaven National Laboratory have for the ... three-dimensional, ordered, crystalline structures of nanoparticles (particles with dimensions ... engineer such 3-D structures is essential to producing functional ...
Cached Biology Technology:Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors 2Genmab's Financial Calendar for 2008 2DNA technique yields 3-D crystalline organization of nanoparticles 2DNA technique yields 3-D crystalline organization of nanoparticles 3
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... WASHINGTON -- The most effective way to prevent the deliberate ... housed in laboratories across the U.S. considered to potentially pose ... culture of trust and responsibility in the laboratory, says a ... the laboratory environment will be critical for identifying and reducing ...
... that the pace of biodiversity loss is worsening in ... Cape Town October 13-16 for the DIVERSITAS Open Science ... of biodiversity have continued to accelerate. Since 1992, the ... than the size of California has been converted mostly ...
... to the AZTI-Tecnalia researchers, the first estimations of the geographical ... undertaken migrations between the Azores and Portugal during the winter, ... and also that it had dived, during the winter, to ... was tagged 26 of August 2008 in the Gulf of ...
Cached Biology News:Securing biological select agents and toxins will require developing a culture of trust 2Securing biological select agents and toxins will require developing a culture of trust 3Juvenile bluefin tunas can dive to depths of more than 1000 meters 2
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
Phospho-Cyclin D1 (Thr286) Antibody...
Biology Products: